What should pediatrician know about selective IgA deficiency (update 2017)
Journal Title: Здоров`я дитини - Year 2017, Vol 12, Issue 7
Abstract
The article presents analysis of the current state of selective immunoglobulin A deficiency (SIgAD) from the point of view of the world’s leading experts, based on the results of epidemiological, genetic, molecular studies with high level of evidence. Selective IgA deficiency is the most common primary immunodeficiency and is characterized by an isolated deficiency of IgA, with usually normal levels of IgM and IgG in patients older than 4 years. Some IgG subclasses may be reduced in some patients with IgA deficiency. It is assumed that the overall incidence of selective IgA deficiency is 1 : 500–1 : 2000, but may be higher as most SIgADs have asymptomatic course, and there is no IgA deficiency screening program. IgA deficiency is facilitated by a complex network of genetic effects, namely IFIH1 loci on chromosome 2 and HLA-DQA1 on chromosome 6, with IgA-deficient-linked PVT1 (8 chromosomes), ATG13-AMBRA1 (11 chromosomes), AHI1 (6 chromosomes), and CLEC16A (16 chromosomes), including genes that are known to affect the physiology of IgA production. Most people with SIgAD are asymptomatic carriers, for some patients, pulmonary infections, allergies, autoimmune diseases, gastrointestinal diseases and malignant neoplasms are characteristic. Monitoring of patients with SIgAD consists of various methods, including education, the treatment of allergic or autoimmune diseases, the use of long courses or even the prophylactic use of antibiotics, the use of polyvalent pneumococcal vaccines and intravenous or subcutaneous substitution therapy with immunoglobulins. SIgAD prognosis mainly depends on the phenotype. There have been rare cases of spontaneous recovery, especially in young patients. Rarely, selective IgA deficiency may progress to the overall variable immunodeficiency. We consider it expedient to use the world experience in the diagnosis and treatment of selective IgA deficiency as the basis for patients’ monitoring in Ukraine.
Authors and Affiliations
O. L. Logvinova, M. O. Gonchar, O. P. Pomazunovska
Keywords
Related Articles
- EP ID EP249235
- DOI 10.22141/2224-0551.12.7.2017.116188
- Views 78
- Downloads 0
Features of Bronchial Asthma in Children with Overweight and Obesity
The article deals with the problem of comorbidity of bronchial asthma in children with overweight and obesity. The basic pathogenetic mechanisms of correlation between bronchial asthma and overweight and obesity are des...
Treatment of Acute Intestinal Infections in Children
The article deals with one of the most serious problems in pediatrics — acute intestinal infections. The issues of treatment — rehydration, antibiotic therapy, adjuvant therapy are considered in detail. The recommendatio...
Modern Approaches to the Diagnosis and Treatment of Tonsillopharyngitis (Review of International Guidelines)
The article presents an overview of guidelines on the treatment of tonsillopharyngitis in children. Attention is given to the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in this pathology. It is emphasized that...
Using Recombinant Interferon Alpha-2b in Pediatric Practice
Interferon system is a key element of antiviral defense of the child’s body that etiopathogenetically justifies the use of nasal and rectal formulations of recombinant interferon alfa-2b for the prevention and treatment...
Diet Therapy in Infants with Rotavirus Infection
In 65 children aged 3–18 months with rotavirus gastroenteritis, we have studied the effectiveness of using lactose-free formula in the diet therapy. It was found that lactose-free diet in patients contributes to a positi...